Latest news
Loading news…
Tozaro
ActiveOperating status — whether the company still runs independently. “Closed” usually means it was acquired, merged, or shut down.🔥 HighHeat score — how much recent activity & attention the company has (web traffic, news, hiring).📈 Low growthGrowth score — momentum trend across web traffic, headcount and other growth signals. Bedford, Bedfordshire, United Kingdom Founded 2015 11-50 employees For Profit
Tozaro is a biotechnology company that develops synthetic affinity reagents for cell and gene therapy.
Total Funding
Available in Pro Last Funding
Available in Pro Acquisitions
0
Monthly Visits
Available in Pro Contacts
17
Patents
2
1 trademarks
Company Details
Funding & Financials
Pro- Total funding
- Funding rounds
- Last funding
- Last funding type
- Last funding date
- Funding status
- Total equity funding
- Revenue range
IPO & Stock
- IPO status
- Private
Web Traffic
Pro- Monthly visits
- Global traffic rank
- 6-mo avg visits
- Visit duration (s)
- Pages / visit
- Bounce rate
- Rank change (mo)
Technology & IP
- Active technologies
- 1
- Patents granted
- 2
- Trademarks
- 1
- Top patent class
- Biochemistry; Beer; Spirits; Wine; Vinegar; Microbiology; Enzymology; Mutation Or Genetic Engineering
- IT spend
- $9M
Company Info
- Founded
- 2015
- Employees
- 11-50
- Operating status
- Active
- Company type
- For Profit
- Org types
- company
- News articles
- 21
- HQ
- Bedford, Bedfordshire, United Kingdom
- Region
- Europe, Middle East, and Africa (EMEA)
Signals & Scores
- Heat score
- High
- Growth score
- Low
- Trend (7d)
- 0.1
- Trend (30d)
- 2.6
- Trend (90d)
- 0.4
- Last leadership hire
- May 14, 2025
Key People at Tozaro
Chief Executive Officer
17
professional contacts at Tozaro
Contact execs at Tozaro →Explore 200,000+ acquisitions — free
Filter the full database across sectors, companies, dates, and deal sizes. No signup, no paywall.
Recent News related to Tozaro
Loading news…
FAQs about Tozaro
People who checked this page also checked these
Browse the full Acquirezy directory.